Form 4: Astrana Health CEO Brandon Sim Reports Stock Transactions
SEC Form 4 Filing
Astrana Health's CEO, Brandon Sim, reported the surrender of shares to cover tax obligations and discloses holdings including restricted stock units and shares held in irrevocable trusts.
Summary
- On October 2, 2024, Brandon Sim, CEO and President of Astrana Health, Inc., reported a transaction involving common stock.
- Sim surrendered 2,626 shares to cover tax withholding obligations at a price of $57.87 per share.
- Following the transaction, Sim directly owns 948,986 shares of common stock, which includes unvested restricted stock and shares acquired under the Employee Stock Purchase Plan.
- Sim also indirectly owns 258,824 shares through the Sim Family Irrevocable Trust 2021 and 392,816 shares through the Brandon Sim 2020 Irrevocable Trust.
- The report details the vesting schedule for the unvested restricted stock, which is contingent upon continuous employment with the Issuer and achievement of certain performance goals.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions. The CEO surrendering shares for tax obligations is a normal occurrence, and the continued vesting of restricted stock indicates ongoing commitment.
Positives
- The CEO's continued holding of a significant number of shares demonstrates a vested interest in the company's success.
- The vesting schedule of restricted stock units incentivizes long-term performance and commitment from the CEO.
Future Outlook
The vesting of restricted stock units is contingent upon continuous employment and achievement of performance goals, suggesting an incentive for the CEO to remain with the company and drive performance.
Industry Context
Form 4 filings are a standard part of regulatory compliance for publicly traded companies, providing transparency into insider transactions. This filing indicates the CEO's ongoing investment in the company.
Stakeholder Impact
- The disclosure provides transparency to shareholders regarding insider transactions.
- The vesting schedule of restricted stock units aligns management's interests with those of long-term shareholders.
Key Dates
| Date | Description |
|---|---|
| 07/26/2024 | Date of Power of Attorney execution. |
| 10/02/2024 | Date of stock transaction (surrender of shares for tax obligations). |
| 10/04/2024 | Date of Form 4 filing. |
| 11/02/2024 | Vesting date for 14,151 restricted shares. |
| 03/31/2025 | Start date for semi-annual vesting of 85,513 shares. |
| 04/02/2025 | Start date for semi-annual vesting of 75,517 restricted stock units. |
| 06/27/2025 | First annual installment vesting date for 54,280 shares and 5,557 shares. |
| 06/27/2026 | Second annual installment vesting date for 54,280 shares and 5,557 shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.